Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Novavax Inc. logo

Novavax Inc.

Sector: Healthcare   

Industry: Biotechnology

4.85
 
USD
  
0.14
  
(2.97%)
Optionable: Yes  Market Cap: 659 M  90-day average vol: 8,636,842

Previous close: 4.71  Open: 4.73  Bid: 4.8  Ask: 4.82
52 week range    
3.53   
   11.36
Peers   
SRPT / 
AGEN / 
BCRX / 
EBS / 
GSK / 
NNVC / 
PFE / 
NVS / 
AZN / 
Last updated: Thursday 28th March 2024
35
MarketXLS Rank
40
Value
15
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

NVAX Cash Flow

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
(Increase) Decrease in inventories-9 M-478 M
(Increase) Decrease in other current liabilities362000.0199000.038 M-3 M-3 M-16 M-8 M272 M1,326 M-1,046 M
(Increase) Decrease in payables4 M14 M9 M-5 M5 M-7 M-11 M163 M600 M913 M
(Increase) Decrease in receivables-4 M-4 M8 M2 M246 M144 M
Acquisitions3 M-171000.0-166 M
AssetImpairmentCharge-4 M
CapitalExpenditureReported6 M7 M18 M18 M4 M1 M2 M55 M57 M93 M
Cash at beginning of period17 M119 M32 M93 M179 M135 M82 M82 M649 M1,528 M
Cash at end of period119 M32 M93 M144 M135 M82 M82 M649 M1,528 M1,349 M
Cash flow-45 M-68 M-90 M-259 M-144 M-185 M-137 M-43 M323 M-416 M
CashFlowFromContinuingInvestingActivities16 M-129 M-57 M31 M36 M29 M38 M-378 M100 M-93 M
ChangeInAccountPayable4 M14 M9 M-5 M5 M-7 M-11 M163 M600 M913 M
ChangeInPayablesAndAccruedExpense4 M14 M9 M-5 M5 M-7 M-11 M163 M600 M913 M
ChangeInPrepaidAssets402000.0-6 M-10 M-1 M3 M1 M-4 M-423 M-183 M249 M
ChangeInWorkingCapital1 M4 M45 M-9 M5 M-21 M-24 M258 M1,734 M-361 M
ChangesInAccountReceivables-451000.0-6 M8 M2 M
Depreciation3 M4 M6 M9 M10 M8 M6 M5 M13 M29 M
Depreciation unreconciled3 M5 M7 M10 M11 M10 M7 M5 M13 M29 M
DepreciationAndAmortization3 M5 M7 M10 M11 M10 M7 M5 M13 M29 M
Effect of exchange rate changes4000.0-6000.0-150000.0-335000.0142000.0-48000.0-32000.02 M-5 M5 M
FinancingCashFlow131 M110 M208 M279 M65 M103 M98 M985 M462 M325 M
Free cash flow-51 M-75 M-108 M-277 M-149 M-186 M-138 M-97 M268 M-505 M
GainLossOnInvestmentSecurities-267000.0-615000.0
GainLossOnSaleOfPPE-32000.0534000.0681000.0374000.0269000.0-55000.0-9 M
IncomeTaxPaidSupplementalData13 M18 M
InterestPaidSupplementalData177000.0179000.096000.06 M12 M12 M12 M14 M19 M18 M
Issuance of capital stock129 M108 M204 M63 M100 M97 M876 M565 M249 M
Issuance of debt1 M-2000.0-126000.0-819000.0
IssuanceOfCapitalStock129 M108 M204 M63 M100 M97 M876 M565 M249 M
IssuanceOfDebt889000.0-797000.0-793000.0324 M-37000.0-96 M-128 M76 M
Net cash from financing activities131 M110 M208 M279 M65 M103 M98 M985 M462 M325 M
Net cash from investing activities16 M-129 M-57 M31 M36 M29 M38 M-378 M100 M-93 M
Net cash from operating activities-45 M-68 M-90 M-259 M-144 M-185 M-137 M-43 M323 M-416 M
Net change in cash & cash equivalents102 M-87 M61 M51 M-44 M-53 M189000.0569 M880 M-179 M
Net income from continuing operations-52 M-83 M-157 M-280 M-184 M-185 M-133 M-418 M-1,744 M-658 M
NetBusinessPurchaseAndSale3 M-171000.0-166 M
NetCommonStockIssuance129 M108 M204 M63 M100 M97 M876 M565 M249 M
NetInvestmentPropertiesPurchaseAndSale19 M-121 M-39 M50 M40 M30 M40 M-158 M158 M
NetInvestmentPurchaseAndSale19 M-121 M-39 M50 M40 M30 M40 M-158 M158 M
NetIssuancePaymentsOfDebt889000.0-797000.0-793000.0324 M-37000.0-96 M-128 M76 M
NetLongTermDebtIssuance-560000.0-795000.0-667000.0325 M-37000.0-96 M-128 M76 M
NetPPEPurchaseAndSale-6 M-7 M-18 M-18 M-4 M-1 M-2 M-55 M-55 M-89 M
NetPreferredStockIssuance200 M
NetTechnologyPurchaseAndSale-3 M-4 M
Operating (gains) losses-32000.0-81000.0681000.0374000.0269000.0-55000.0-9 M
Other financing charges net-39 M-39 M25 M-639000.0
Other investing changes net-431000.01 M-36 M3 M6 M18 M
Other non-cash items2 M6 M14 M20 M23 M12 M22 M113 M320 M574 M
PreferredStockIssuance200 M
ProceedsFromStockOptionExercised1 M3 M5 M4 M1 M3 M992000.05 M25 M
Purchase of Float term investments-15 M-17 M-363 M-2 M
Purchase of property plant & equipment-6 M-7 M-18 M-18 M-4 M-1 M-2 M-55 M-55 M-89 M
Purchase of short term investments325 M175 M
PurchaseOfInvestment-15 M-176 M-229 M-357 M-218 M-120 M-17 M-363 M-2 M
PurchaseOfLongTermInvestments-15 M-176 M-229 M-357 M-218 M-120 M
PurchaseOfPPE-6 M-7 M-18 M-18 M-4 M-1 M-2 M-55 M-55 M-89 M
PurchaseOfTechnology-3 M-4 M
Repayment of debt-560000.0-795000.0-667000.0-466000.0-37000.0-96 M-128 M-99 M
RepaymentOfDebt-561000.0-797000.0-793000.0-1 M-37000.0-96 M-128 M-99 M
Revenue per share507000.0415000.01 M1 M1 M1 M1 M1 M
Sale of short term investments34 M54 M226 M403 M258 M150 M40 M206 M160 M
SaleOfInvestment34 M54 M226 M403 M258 M150 M40 M206 M160 M
SaleOfPPE116000.039000.018000.011000.0
ShortTermDebtIssuance1 M
ShortTermDebtPayments-1000.0-2000.0-126000.0-819000.0
StockBasedCompensation2 M6 M13 M19 M20 M18 M17 M128 M184 M130 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University